Heart Disease News and Research

Latest Heart Disease News and Research

Model simulates dynamics of heart rhythm disorders

Dutch researcher Kirsten ten Tusscher has developed a model that can simulate the electrical behaviour of the heart during heart rhythm disorders. One of the things her model revealed is that the electrical activity of the heart during a rhythm disorder is much less chaotic than was originally thought.

20 Dec 2004

Pacemakers could play a future role in protecting epilepsy patients

Results of a UK study in this week’s issue of THE LANCET highlight how interruptions to the heart’s rhythm is an under-reported consequence of epileptic seizures, and that the use of cardiac pacemakers by some epilepsy patients could play a future role in protecting against sudden unexplained death.

20 Dec 2004

Discovery of new compound known as SP-4-84 could lead to improved chemotherapy treatments

The discovery of a new compound by Michigan State University researchers could lead to improved chemotherapy treatments for different types of cancers – potentially with fewer side effects.

20 Dec 2004

Wine, fish, dark chocolate, fruits and vegetables cut the risk of heart disease

Scientists in this week's Christmas issue of the BMJ have discovered the 'Polymeal', a set of ingredients which cuts the risk of heart (cardiovascular) disease by 76% and significantly increases life expectancy.

20 Dec 2004

Celebrex suspension

The National Institutes of Health (NIH) announced that it has suspended the use of COX-2 inhibitor celecoxib (Celebrex™ Pfizer, Inc.) for all participants in a large colorectal cancer prevention clinical trial conducted by the National Cancer Institute (NCI).

19 Dec 2004

10 to 20 million people in the United States have chronic kidney disease but most don’t know it

10 to 20 million people in the United States have chronic kidney disease but most don’t know it, according to a study by researchers at the Johns Hopkins Bloomberg School of Public Health, the National Institute of Diabetes and Digestive and Kidney Diseases and the National Center for Health Statistics.

19 Dec 2004

Obesity drug codenamed AOD9604 highly successful in trials

An Australian-owned obesity drug, developed by Melbourne-based biotechnology company Metabolic Pharmaceuticals Limited, is set to enter final human trials next year after successfully completing a Phase 2b human trial which proved that the drug induces weight loss and is very well tolerated with no evidence of the side effects commonly experienced with existing obesity drugs.

16 Dec 2004

Low-dose diuretic therapy for most patients with hypertension recommended

Patients with high blood pressure who take calcium channel blockers and diuretics have an increased risk for cardiovascular disease (CVD) death compared to patients who take beta-blockers plus diuretics, according to a study in the current issue of JAMA.

16 Dec 2004

Cardiac and non-cardiac deaths peak during Christmas and New Year’s in part because people delay seeking medical treatment

Cardiac and non-cardiac deaths peak during Christmas and New Year’s in part because people delay seeking medical treatment, researchers report in today’s Circulation: Journal of the American Heart Association.

14 Dec 2004

High pressure work deadlines boost heart attack risk six-fold

A high pressure work deadline boosts the chances of a heart attack within the next 24 hours by a factor of six, reveals research in the Journal of Epidemiology and Community Health.

13 Dec 2004

Race may play an important role in determining a person's obesity and fitness levels

Race may play an important role in determining a person's obesity and fitness levels, shows a new study in the December issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians (ACCP).

13 Dec 2004

Detrol LA significantly reduces symptoms of overactive bladder

Pfizer today announced results of a comprehensive six-year review of efficacy and safety data for Detrol LA (tolterodine tartrate extended release capsules) indicating that Detrol LA significantly reduces symptoms of overactive bladder (OAB) with a low occurrence of side effects, and should be considered first-line therapy.

13 Dec 2004

Risk of having a heart attack is elevated in the weeks after stopping use of nonsteroidal anti-inflammatory drugs

The risk of having a heart attack is elevated in the weeks after stopping use of nonsteroidal anti-inflammatory drugs, according to an article in the December issue of The Archives of Internal Medicine, one of the JAMA/Archives journals.

13 Dec 2004

Ads for full-body scans to detect potential diseases, called into question

A burgeoning industry that sells full-body scans to detect potential diseases - without a doctor's referral - is running advertisements that frequently include unsubstantiated claims about the benefits of getting CT and MRI scans, while rarely providing information about the technology's limitations and risks.

13 Dec 2004

Compounds in Christmas trees could help treat arthritis and pain

Researchers have identified a group of anti-inflammatory compounds in the bark of the Scotch pine - widely used for Christmas trees - that they say could be developed into food supplements or drugs for treating arthritis and pain.

13 Dec 2004

Association between gastrointestinal disorders and sleep disturbances

Mayo Clinic researchers report in the current issue of Mayo Clinic Proceedings an association between gastrointestinal disorders and sleep disturbances. The association is important because these problems cause significant health issues including greater need for general medical and mental health treatment.

13 Dec 2004

Landmark revascularization procedure

The People's Hospital of Beijing University performed a combined revascularization procedure utilizing beating heart bypass surgery, along with transmyocardial revascularization and stem cell implantation.

13 Dec 2004

Obesity rate among American workers of all ages grew from 20% to 29% over the past decade

The obesity rate among American workers of all ages grew from 20% to 29% over the past decade, leading to serious repercussions in the workplace and a demand for solutions, according to a new Pfizer Inc study published today in the Journal of Occupational and Environmental Medicine.

13 Dec 2004

Novel anti-rejection protocol should allow major improvement efficacy and quality of life after intestinal and multivisceral transplants

Transplant researchers at the University of Pittsburgh's Thomas E. Starzl Transplantation Institute have dramatically improved intestinal transplant graft survival, and reduced rejection and infection rates by successfully using a novel immunosuppression minimization protocol, thus improving patients' overall quality of life and avoiding the use of several anti-rejection drugs, which can cause serious infections and major complications.

13 Dec 2004

Cell replacement therapy offers a novel and powerful medical technology

Cell replacement therapy offers a novel and powerful medical technology. A type of embryonic stem cell, called a neural crest stem cell, that persists into adulthood in hair follicles was recently discovered by Maya Sieber-Blum, Ph.D., of the Medical College of Wisconsin, Milos Grim, MD Ph.D., of Charles University Prague, and their collaborators.

13 Dec 2004